SEK141.70
2.31% yesterday
Stockholm, Nov 15, 05:29 pm CET
ISIN
SE0014428512
Symbol
SUS
Sector

Surgical Science Sweden AB Stock price

SEK141.70
+16.40 13.09% 1M
+7.90 5.90% 6M
-40.80 22.36% YTD
-17.40 10.94% 1Y
-182.80 56.33% 3Y
+57.70 68.69% 5Y
+113.10 395.45% 10Y
Stockholm, Closing price Fri, Nov 15 2024
+3.20 2.31%
ISIN
SE0014428512
Symbol
SUS
Sector

Key metrics

Market capitalization SEK7.23b
P/E (TTM) P/E ratio 36.57
P/S ratio (TTM) P/S ratio 8.63
P/B ratio (TTM) P/B ratio 1.57
Revenue growth (TTM) Revenue growth -6.91%
Revenue (TTM) Revenue SEK838.25m
EBIT (operating result TTM) EBIT SEK153.90m
Free Cash Flow (TTM) Free Cash Flow SEK141.43m
Cash position SEK667.08m
EPS (TTM) EPS SEK3.88
P/E forward 49.63
P/S forward 7.88
Show more

Is Surgical Science Sweden AB a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.

Surgical Science Sweden AB Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a Surgical Science Sweden AB forecast:

5x Buy
100%

Analyst Opinions

5 Analysts have issued a Surgical Science Sweden AB forecast:

Buy
100%

Financial data from Surgical Science Sweden AB

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
838 838
7% 7%
100%
- Direct Costs 320 320
8% 8%
38%
519 519
6% 6%
62%
- Selling and Administrative Expenses 145 145
11% 11%
17%
- Research and Development Expense 162 162
5% 5%
19%
211 211
16% 16%
25%
- Depreciation and Amortization 58 58
6% 6%
7%
EBIT (Operating Income) EBIT 154 154
23% 23%
18%
Net Profit 198 198
15% 15%
24%

In millions SEK.

Don't miss a Thing! We will send you all news about Surgical Science Sweden AB directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Surgical Science Sweden AB engages in the development of simulators for laparoscopic medical training. Its products include LapSim, offers a procedural simulation for cholecystectomy, appendectomy, advanced suturing and anastomosis, gynecology, hysterectomy, bariatrics, and nephrectomy; EndoSim, for endoscopy simulation; and TeamSim, for realistic training of collaboration within a surgery team. The company was founded by Anders Hyltander, David Löfstrand, and Anders Larsson on July 24, 1997 and is headquartered in Gothenburg, Sweden.

Head office Sweden
CEO Tom Englund
Employees 260
Founded 1997
Website www.surgical-science.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today